BioCentury
ARTICLE | Company News

Ascletis, Roche deal

April 22, 2013 7:00 AM UTC

Roche granted Ascletis exclusive, Chinese rights to the pharma's HCV compound danoprevir. Under the deal, Ascletis will fund development, regulatory affairs and manufacturing in China. The partners wi...